Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/CRP ratio (LCR) are Reliable Predictors of Adverse Outcomes in High-Altitude COVID-19 Patiens

Descripción del Articulo

The neutrophil/lymphocyte ratio (NLR) and the lymphocyte/C-reactive protein ratio (LCR) are prognostic factors in inflammatory, cardiovascular, and oncological dis eases. With the emergence of the COVID-19 pandemic, it has been recently shown that NLR and LCR are also useful for the prognosis of dis...

Descripción completa

Detalles Bibliográficos
Autores: Jimenez-Aguilar, Rosalinda, Merino-Luna, Alfredo, Arias-Reyes, Christian, Lozada-Mata, Maria Paola, Tenorio-Gutierrez, Willebaldo, Romero Martinez, Martin, Duenas, Enrique, Viruez-Soto, Antonio, Molano-Franco, Daniel, Zubieta-Calleja, Gustavo, Zubieta-DeUrioste, Natalia, Carmona Suazo, Jose Antonio, Tinoco-Solorzano, Amilcar, Sanchez, Lida, Soliz, Jorge
Formato: artículo
Fecha de Publicación:2023
Institución:Seguro Social de Salud
Repositorio:ESSALUD-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.essalud.gob.pe:20.500.12959/5771
Enlace del recurso:https://hdl.handle.net/20.500.12959/5771
https://doi.org/10.18103/mra.v11i8.4300
Nivel de acceso:acceso abierto
Materia:SARS-COV-2
High altitude
Disease severity
Mortality
Inflammation
Prognosis
https://purl.org/pe-repo/ocde/ford#3.03.08
https://purl.org/pe-repo/ocde/ford#3.03.09
id ESSA_3907a2a55c5f92f3a093a436036ae63b
oai_identifier_str oai:repositorio.essalud.gob.pe:20.500.12959/5771
network_acronym_str ESSA
network_name_str ESSALUD-Institucional
repository_id_str 4277
dc.title.es_PE.fl_str_mv Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/CRP ratio (LCR) are Reliable Predictors of Adverse Outcomes in High-Altitude COVID-19 Patiens
title Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/CRP ratio (LCR) are Reliable Predictors of Adverse Outcomes in High-Altitude COVID-19 Patiens
spellingShingle Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/CRP ratio (LCR) are Reliable Predictors of Adverse Outcomes in High-Altitude COVID-19 Patiens
Jimenez-Aguilar, Rosalinda
SARS-COV-2
High altitude
Disease severity
Mortality
Inflammation
Prognosis
https://purl.org/pe-repo/ocde/ford#3.03.08
https://purl.org/pe-repo/ocde/ford#3.03.09
title_short Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/CRP ratio (LCR) are Reliable Predictors of Adverse Outcomes in High-Altitude COVID-19 Patiens
title_full Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/CRP ratio (LCR) are Reliable Predictors of Adverse Outcomes in High-Altitude COVID-19 Patiens
title_fullStr Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/CRP ratio (LCR) are Reliable Predictors of Adverse Outcomes in High-Altitude COVID-19 Patiens
title_full_unstemmed Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/CRP ratio (LCR) are Reliable Predictors of Adverse Outcomes in High-Altitude COVID-19 Patiens
title_sort Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/CRP ratio (LCR) are Reliable Predictors of Adverse Outcomes in High-Altitude COVID-19 Patiens
author Jimenez-Aguilar, Rosalinda
author_facet Jimenez-Aguilar, Rosalinda
Merino-Luna, Alfredo
Arias-Reyes, Christian
Lozada-Mata, Maria Paola
Tenorio-Gutierrez, Willebaldo
Romero Martinez, Martin
Duenas, Enrique
Viruez-Soto, Antonio
Molano-Franco, Daniel
Zubieta-Calleja, Gustavo
Zubieta-DeUrioste, Natalia
Carmona Suazo, Jose Antonio
Tinoco-Solorzano, Amilcar
Sanchez, Lida
Soliz, Jorge
author_role author
author2 Merino-Luna, Alfredo
Arias-Reyes, Christian
Lozada-Mata, Maria Paola
Tenorio-Gutierrez, Willebaldo
Romero Martinez, Martin
Duenas, Enrique
Viruez-Soto, Antonio
Molano-Franco, Daniel
Zubieta-Calleja, Gustavo
Zubieta-DeUrioste, Natalia
Carmona Suazo, Jose Antonio
Tinoco-Solorzano, Amilcar
Sanchez, Lida
Soliz, Jorge
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Jimenez-Aguilar, Rosalinda
Merino-Luna, Alfredo
Arias-Reyes, Christian
Lozada-Mata, Maria Paola
Tenorio-Gutierrez, Willebaldo
Romero Martinez, Martin
Duenas, Enrique
Viruez-Soto, Antonio
Molano-Franco, Daniel
Zubieta-Calleja, Gustavo
Zubieta-DeUrioste, Natalia
Carmona Suazo, Jose Antonio
Tinoco-Solorzano, Amilcar
Sanchez, Lida
Soliz, Jorge
dc.subject.es_PE.fl_str_mv SARS-COV-2
High altitude
Disease severity
Mortality
Inflammation
Prognosis
topic SARS-COV-2
High altitude
Disease severity
Mortality
Inflammation
Prognosis
https://purl.org/pe-repo/ocde/ford#3.03.08
https://purl.org/pe-repo/ocde/ford#3.03.09
dc.subject.ocde.es_PE.fl_str_mv https://purl.org/pe-repo/ocde/ford#3.03.08
https://purl.org/pe-repo/ocde/ford#3.03.09
description The neutrophil/lymphocyte ratio (NLR) and the lymphocyte/C-reactive protein ratio (LCR) are prognostic factors in inflammatory, cardiovascular, and oncological dis eases. With the emergence of the COVID-19 pandemic, it has been recently shown that NLR and LCR are also useful for the prognosis of disease severity in patients infected with the SARS-CoV-2 virus at sea level. However, there are no studies demon strating the reliability of NLR and LCR in high-altitude human populations (above 2,500 m). This is relevant because both the incidence and mortality from COVID-19 are decreased in high altitude. A possible explanation of this effect is a lower impact of this virus on the exaggerated inflammatory response induced by the viral infection. The aim of this study is to determine whether the NLR and LCR indices can be used as reliable predictive markers of COVID-19 severity in high-altitude permanent resident patients. Routine blood biochemistry and complete blood count were performed on 368 patients positive for the SARS-CoV-2 virus in Huaraz, Peru (3,050 m). Patients’ follow up was carried out until home discharge or fatal outcome. The results show that: 1) NLR values are higher in deceased patients admitted to the intensive care unit due to COVID-19; 2) NLR and LCR are reliable predictors of death in patients with COVID-19; and 3) NLR and LCR are reliable predictors of intensive care unit require ment in COVID-19 patients. We conclude that NLR and LCR are reliable biomarkers and prognostic factors of COVID-19 severity and can be used in high-altitude per manent resident patients.
publishDate 2023
dc.date.accessioned.none.fl_str_mv 2025-11-26T20:07:48Z
dc.date.available.none.fl_str_mv 2025-11-26T20:07:48Z
dc.date.issued.fl_str_mv 2023-08-31
dc.type.es_PE.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.citation.es_PE.fl_str_mv Medical Research Archives. 2023, 11(8).
dc.identifier.issn.none.fl_str_mv 2375-1924
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12959/5771
dc.identifier.doi.none.fl_str_mv https://doi.org/10.18103/mra.v11i8.4300
identifier_str_mv Medical Research Archives. 2023, 11(8).
2375-1924
url https://hdl.handle.net/20.500.12959/5771
https://doi.org/10.18103/mra.v11i8.4300
dc.language.iso.es_PE.fl_str_mv eng
language eng
dc.relation.uri.es_PE.fl_str_mv https://esmed.org/MRA/mra/article/view/4300
dc.rights.es_PE.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.es_PE.fl_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.format.es_PE.fl_str_mv application/pdf
dc.publisher.es_PE.fl_str_mv European Society of Medicine
dc.source.none.fl_str_mv reponame:ESSALUD-Institucional
instname:Seguro Social de Salud
instacron:ESSALUD
instname_str Seguro Social de Salud
instacron_str ESSALUD
institution ESSALUD
reponame_str ESSALUD-Institucional
collection ESSALUD-Institucional
bitstream.url.fl_str_mv https://repositorio.essalud.gob.pe/bitstream/20.500.12959/5771/1/NeutrophilLymphocyte%20Ratio%20%28NLR%29%20and%20LymphocyteCRP%20ratio%20%28LCR%29%20are%20Reliable%20Predictors%20of%20Adverse%20Outcomes%20in%20High-Altitude%20COVID-19%20Patiens.pdf
https://repositorio.essalud.gob.pe/bitstream/20.500.12959/5771/2/license.txt
https://repositorio.essalud.gob.pe/bitstream/20.500.12959/5771/3/NeutrophilLymphocyte%20Ratio%20%28NLR%29%20and%20LymphocyteCRP%20ratio%20%28LCR%29%20are%20Reliable%20Predictors%20of%20Adverse%20Outcomes%20in%20High-Altitude%20COVID-19%20Patiens.pdf.txt
https://repositorio.essalud.gob.pe/bitstream/20.500.12959/5771/4/NeutrophilLymphocyte%20Ratio%20%28NLR%29%20and%20LymphocyteCRP%20ratio%20%28LCR%29%20are%20Reliable%20Predictors%20of%20Adverse%20Outcomes%20in%20High-Altitude%20COVID-19%20Patiens.pdf.jpg
bitstream.checksum.fl_str_mv 466f8de1feb7c2c017c9bb8e2ed02f2e
8a4605be74aa9ea9d79846c1fba20a33
99bc43fff8b28a09608ac97156a6d2d4
a35cc886aa4eaf2e89386ca9af5787d8
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Seguro Social de Salud – ESSALUD
repository.mail.fl_str_mv bibliotecacentral@essalud.gob.pe
_version_ 1850953621882011648
spelling Jimenez-Aguilar, RosalindaMerino-Luna, AlfredoArias-Reyes, ChristianLozada-Mata, Maria PaolaTenorio-Gutierrez, WillebaldoRomero Martinez, MartinDuenas, EnriqueViruez-Soto, AntonioMolano-Franco, DanielZubieta-Calleja, GustavoZubieta-DeUrioste, NataliaCarmona Suazo, Jose AntonioTinoco-Solorzano, AmilcarSanchez, LidaSoliz, Jorge2025-11-26T20:07:48Z2025-11-26T20:07:48Z2023-08-31Medical Research Archives. 2023, 11(8).2375-1924https://hdl.handle.net/20.500.12959/5771https://doi.org/10.18103/mra.v11i8.4300The neutrophil/lymphocyte ratio (NLR) and the lymphocyte/C-reactive protein ratio (LCR) are prognostic factors in inflammatory, cardiovascular, and oncological dis eases. With the emergence of the COVID-19 pandemic, it has been recently shown that NLR and LCR are also useful for the prognosis of disease severity in patients infected with the SARS-CoV-2 virus at sea level. However, there are no studies demon strating the reliability of NLR and LCR in high-altitude human populations (above 2,500 m). This is relevant because both the incidence and mortality from COVID-19 are decreased in high altitude. A possible explanation of this effect is a lower impact of this virus on the exaggerated inflammatory response induced by the viral infection. The aim of this study is to determine whether the NLR and LCR indices can be used as reliable predictive markers of COVID-19 severity in high-altitude permanent resident patients. Routine blood biochemistry and complete blood count were performed on 368 patients positive for the SARS-CoV-2 virus in Huaraz, Peru (3,050 m). Patients’ follow up was carried out until home discharge or fatal outcome. The results show that: 1) NLR values are higher in deceased patients admitted to the intensive care unit due to COVID-19; 2) NLR and LCR are reliable predictors of death in patients with COVID-19; and 3) NLR and LCR are reliable predictors of intensive care unit require ment in COVID-19 patients. We conclude that NLR and LCR are reliable biomarkers and prognostic factors of COVID-19 severity and can be used in high-altitude per manent resident patients.application/pdfengEuropean Society of Medicinehttps://esmed.org/MRA/mra/article/view/4300info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/SARS-COV-2High altitudeDisease severityMortalityInflammationPrognosishttps://purl.org/pe-repo/ocde/ford#3.03.08https://purl.org/pe-repo/ocde/ford#3.03.09Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/CRP ratio (LCR) are Reliable Predictors of Adverse Outcomes in High-Altitude COVID-19 Patiensinfo:eu-repo/semantics/articlereponame:ESSALUD-Institucionalinstname:Seguro Social de Saludinstacron:ESSALUDORIGINALNeutrophilLymphocyte Ratio (NLR) and LymphocyteCRP ratio (LCR) are Reliable Predictors of Adverse Outcomes in High-Altitude COVID-19 Patiens.pdfNeutrophilLymphocyte Ratio (NLR) and LymphocyteCRP ratio (LCR) are Reliable Predictors of Adverse Outcomes in High-Altitude COVID-19 Patiens.pdfapplication/pdf342259https://repositorio.essalud.gob.pe/bitstream/20.500.12959/5771/1/NeutrophilLymphocyte%20Ratio%20%28NLR%29%20and%20LymphocyteCRP%20ratio%20%28LCR%29%20are%20Reliable%20Predictors%20of%20Adverse%20Outcomes%20in%20High-Altitude%20COVID-19%20Patiens.pdf466f8de1feb7c2c017c9bb8e2ed02f2eMD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://repositorio.essalud.gob.pe/bitstream/20.500.12959/5771/2/license.txt8a4605be74aa9ea9d79846c1fba20a33MD52TEXTNeutrophilLymphocyte Ratio (NLR) and LymphocyteCRP ratio (LCR) are Reliable Predictors of Adverse Outcomes in High-Altitude COVID-19 Patiens.pdf.txtNeutrophilLymphocyte Ratio (NLR) and LymphocyteCRP ratio (LCR) are Reliable Predictors of Adverse Outcomes in High-Altitude COVID-19 Patiens.pdf.txtExtracted texttext/plain40677https://repositorio.essalud.gob.pe/bitstream/20.500.12959/5771/3/NeutrophilLymphocyte%20Ratio%20%28NLR%29%20and%20LymphocyteCRP%20ratio%20%28LCR%29%20are%20Reliable%20Predictors%20of%20Adverse%20Outcomes%20in%20High-Altitude%20COVID-19%20Patiens.pdf.txt99bc43fff8b28a09608ac97156a6d2d4MD53THUMBNAILNeutrophilLymphocyte Ratio (NLR) and LymphocyteCRP ratio (LCR) are Reliable Predictors of Adverse Outcomes in High-Altitude COVID-19 Patiens.pdf.jpgNeutrophilLymphocyte Ratio (NLR) and LymphocyteCRP ratio (LCR) are Reliable Predictors of Adverse Outcomes in High-Altitude COVID-19 Patiens.pdf.jpgGenerated Thumbnailimage/jpeg7745https://repositorio.essalud.gob.pe/bitstream/20.500.12959/5771/4/NeutrophilLymphocyte%20Ratio%20%28NLR%29%20and%20LymphocyteCRP%20ratio%20%28LCR%29%20are%20Reliable%20Predictors%20of%20Adverse%20Outcomes%20in%20High-Altitude%20COVID-19%20Patiens.pdf.jpga35cc886aa4eaf2e89386ca9af5787d8MD5420.500.12959/5771oai:repositorio.essalud.gob.pe:20.500.12959/57712025-11-27 03:00:45.441Repositorio Seguro Social de Salud – ESSALUDbibliotecacentral@essalud.gob.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
score 13.43078
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).